Found 11 matching trials
PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence PHASE2 Flotufolastat F-18, sold under the brand name Posluma, is a radioactive dia...
Show More Learn More & Join Trial
Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial PHASE2 This phase II trial studies how well a short course of androgen deprivation...
Show More Location
Mayo Clinic in Arizona
Learn More & Join Trial
Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer NA This clinical trial evaluates the use of an imaging scan (18F-rhPSMA-7.3 po...
Show More Location
Mayo Clinic in Florida
Learn More & Join Trial
Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance PHASE2 This investigator-initiated, prospective study evaluates the diagnostic uti...
Show More Location
Mount Sinai Hospital / Icahn School of Medicine at Mount Sinai
Learn More & Join Trial
POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions PHASE2 The goal of this study to determine if using the (18)F-rhPSMA-7.3 PET-CT sc...
Show More Location
UF Health - Jacksonville
Learn More & Join Trial
Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland Treatment NA To evaluate the effectiveness of a PSMA-PET scan in identifying recurrent p...
Show More Location
John Theurer Cancer Center at Hackensack University Medical Center
Learn More & Join Trial
[18F]-rhPSMA PET-CT Imaging Performance in Patients With Prostate Cancer NA This clinical trial evaluates \[18F\]-rh PSMA positron emission tomography ...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial EARLY_PHASE1 This phase II trial evaluates an imaging technique (rhPSMA-7.3 positron emi...
Show More Location
Northwestern University
Learn More & Join Trial
Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate Cancer PHASE2 This is a randomized, open-label, pilot study assessing the impact of a sho...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial EARLY_PHASE1 This early phase I trial evaluates whether a new imaging technique using fl...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial